glp-1 drugs and alcohol Weight Loss May Also Curb Substance Use Disorders GLP-1 drugs and alcohol reduction
Description
Ozempic and Wegovy are proven to significantly lower those risks
Tirzepatide has an obviously lower affinity with GIPR than GIP does (pIC 50 : 6.70 vs 7.87), and its cAMP activity is approximately equal to that of GIP
For weight management specifically, comparisons should reference the higher 2.4 mg dose of semaglutide (Wegovy) rather than the 1 mg dose used for diabetes
Manufacturing considerations also favor tirzepatide for companies with peptide synthesis capabilities
cardiovascular risk)
